We were piloting our prototypes with one of the 3 biggest pharma for a year now and found a very promising use case. Everybody is excited and delighted. Our tool hits the nail on the head for them. Our new upgrade is exactly the thing they need for their strategic async discussions internally and with external key stakeholders, KOLs.